Hall, Amy Jennae,Bland, Jeff,Konda, Veera,Pacioretty, Linda,Tripp, Matthew L.,Babish, John G.
申请号：
AU2012265557
公开号：
AU2012265557A1
申请日:
2012.12.17
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
#$%^&*AU2012265557A120130131.pdf#####C: \NRPortbl\DCC\DAR\489270_l.DOC-17 12/2012 ABSTRACT Disclosed are botanically based compositions and methods useful for the treatment of metabolic syndrome and diabetes type 2. Compositions, kits, and methods are additionally disclosed for means to augment the activity of identified glucose and insulin regulating drugs. Hexahydrocolupulone _-^-7.1 0.57 Spent Hops : 1.11 Beta-Acids 1 .24 Alpha Acids sw ____ _ - 1 1.45 -_- I _ _ ii _ Xanthohumol rrImm mm - 1.46 Hexahydroisoalpha acids Ir:".E 2 Tetrahydroisoalpha acids I m z m4 : 1.79 __I i__ f_ W Rho-isoaipha acids 2.25 Isoaipha acids -____ ____ 2.45 Indomethacin m_ _ ________ . 1.33 Troglitazone - --1 1.43 Solvent Control a 1.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 Relative Nonpolar Lipid ContentWO 2007/070355 PCT/US2006/046770 Hexahydrocolupulone kv e L7.I 10.57 Spent Hops m re me m:I 1.11 Beta-Acids 1 m Thws = - .24 Alpha Acids m n a m 1.45 Xanthohumol r a m a i -1 1.46 Hexahydroisoalpha acids amme-,r sa.a : - 1. 2 Tetrahydroisoalpha acids a mae r1- 1.79 Rho-isoalpha acids a -:" _________ : 2.25 Isoalpha acids a ____________n: 4 2.45 Indomethacin m22, mm5mfer : 1.33 Troglitazone 7,7 .7 77m75,777:77 i 1.43 Solvent Control mi - n ~ 1.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 Relative Nonpolar Lipid Content Fig. 18 18/23
